Cardiologycardiac glycosidesclinical trial
Five Key Lessons From the DIGIT-HF Trial: Revisiting Digitoxin in HFrEF Management
By MedXY|Oct 5, 2025
The DIGIT-HF trial sheds new light on digitoxin’s role in heart failure with reduced ejection fraction, revealing safety, efficacy, and clinical implications despite contemporary therapies.
